30,650 Shares in Aflac Incorporated $AFL Bought by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 30,650 shares of the financial services provider’s stock, valued at approximately $3,594,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC bought a new stake in Aflac in the first quarter valued at approximately $25,000. Groupe la Francaise bought a new position in shares of Aflac during the 1st quarter worth approximately $25,000. Quarry LP acquired a new position in shares of Aflac during the 4th quarter worth approximately $25,000. Edmond DE Rothschild Holding S.A. acquired a new position in shares of Aflac during the 2nd quarter worth approximately $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in Aflac in the 4th quarter valued at $29,000. Institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

Shares of NYSE AFL opened at $116.12 on Friday. The firm has a market cap of $58.22 billion, a P/E ratio of 12.45, a price-to-earnings-growth ratio of 1.87 and a beta of 0.60. The business’s 50 day moving average is $121.55 and its 200-day moving average is $116.12. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $104.66 and a 1-year high of $130.22.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Thursday, August 6th. The financial services provider reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.76 by ($0.01). The firm had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. Aflac had a net margin of 26.91% and a return on equity of 13.27%. The business’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 earnings per share. Equities research analysts predict that Aflac Incorporated will post 7.04 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Wednesday, August 19th will be given a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Wednesday, August 19th. Aflac’s payout ratio is presently 26.15%.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 600 shares of Aflac stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $124.10, for a total value of $74,460.00. Following the completion of the sale, the director owned 32,710 shares in the company, valued at $4,059,311. The trade was a 1.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Post Holdings Co. Ltd. Japan sold 12,700 shares of the business’s stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $117.05, for a total transaction of $1,486,535.00. Following the completion of the sale, the insider directly owned 50,817,790 shares of the company’s stock, valued at $5,948,222,319.50. This represents a 0.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 497,625 shares of company stock valued at $58,356,483. 0.80% of the stock is currently owned by company insiders.

Aflac News Roundup

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Aflac’s quarterly dividend is $0.61 per share, or $2.44 annualized, providing a yield of roughly 2.1%. The company has a long record of dividend growth and a relatively low payout ratio of about 26%, supporting its appeal as a defensive income stock.
• Neutral Sentiment: Recent earnings were mixed: quarterly revenue of $4.22 billion exceeded analyst expectations of $4.11 billion, but earnings per share of $1.75 narrowly missed the $1.76 consensus. Revenue declined 1% year over year and EPS fell from $1.78 in the prior-year quarter, limiting fundamental momentum.
• Neutral Sentiment: Wall Street’s overall view remains cautious, with a consensus rating of “Hold” and an average price target near $116.62. Some analysts remain constructive, including Piper Sandler with a $138 target, while others maintain neutral or underweight ratings.
• Negative Sentiment: Wolfe Research initiated coverage with an “underperform” rating and a $103 price target, implying meaningful downside from recent trading levels. The call adds to existing concerns from Barclays and JPMorgan, which also have cautious ratings or targets. Wolfe Research Starts Aflac at Underperform
• Negative Sentiment: Japan Post Holdings, Aflac’s major shareholder, sold another 12,700 shares on August 19 for approximately $1.49 million, following sales of 14,200 shares on August 18 and 13,900 shares on August 17. The transactions were conducted under a pre-arranged Rule 10b5-1 plan and represent only a small reduction in its stake, but the repeated selling may weigh on investor sentiment. Aflac SEC Insider Filing

Wall Street Analyst Weigh In

AFL has been the subject of several research reports. UBS Group reaffirmed a “neutral” rating and set a $124.00 price target (up from $114.00) on shares of Aflac in a report on Wednesday, July 8th. Wall Street Zen downgraded shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. JPMorgan Chase & Co. dropped their price objective on shares of Aflac from $117.00 to $116.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Barclays restated an “underweight” rating and set a $99.00 target price (up from $98.00) on shares of Aflac in a research note on Friday, August 7th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of Aflac from $120.00 to $125.00 and gave the stock a “market perform” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $116.62.

Aflac Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.